Remicade (infliximab) - J&J
Rinvoq (upadacitinib) - AbbVie
vancomycin - Generic mfg.
Keytruda (pembrolizumab) - Merck (MSD)
Dificid (fidaxomicin) - Merck (MSD), Astellas
Looking Beyond Clostridioides Difficile: Persistent Diarrhea Unmasking PembrolizumabâInduced ImmuneâMediated Colitis (ACG 2026) - Aug 29, 2026 - Abstract #P5898; Pres time: Oct 13, 2026; 10:30 AM - 04:00 PM; Location: Exhibit Halls A - D (Level 3); "She continued to have 5â7 loose bowel movements daily and crampy abdominal pain despite oral vancomycin and a switch to fidaxomicin after 5 days...Disease was refractory to corticosteroids and infliximab but ultimately responded to upadacitinib...Figure: Figure 2. Gross bloody diarrheal stool and representative colonoscopic images from the ascending, descending, and sigmoid colon demonstrating diffuse erythema, friability, and ulceration, consistent with severe pancolitis due to immuneâmediated colitis in the setting of pembrolizumab therapy." 
Gastroenterology • Gastrointestinal Disorder • Immunology • Infectious Disease • Lung Cancer • Solid Tumor
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=827318&rnd=0.8611707
 
Keeranmayee Mishra MD 1; Chirag Doshi MS 2; Apurba Mishra MSc 3; Pavani Narsapuram MBBS MD 4; Mrudulla Alla MD 1; Ravi K. Patel MD 1; Rakshana Ravichandran MD 1; Aditya Kohli MD 5; Bireera Muzaffar MD 6; Mihaela Batke MD 7
 
Aug 29, 2026
 
Prev Next